StorageStore in a refrigerator 2°C to 8°C (36°F to 46°F). dacarbazine Use within 8 hours of reconstitution. Protect from light
Supply TypeManufacturer, Exporter, Supplier
Preferred Buyer Location
All over the world
Dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. In addition, dacarbazine for injection is also indicated for Hodgkin's disease as a secondary-line therapy when used in combination with other effective agents.
Malignant melanoma : 2-4.5 mgkgday for 10 days may be repeated at 4 weeks intervel or 250 mgml of body surface area (BSA)day for 5 days repeated after 3 weeks. Hodgkin's disease : 150mgm² to be repeated every 15 days.
Dacarbazine for injection is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.